Meanwhile, research into serological TK1’s use in predicting precancer in a study involving 56,178 people showed that serological TK1 protein is a potential proliferative biomarker for early discovery of persons at risk for the development of, or who already have, malignancies or diseases associated with the development of malignancies (Wang et al., 2018). Here, TK1 is linked to cancer.